-

HMRI Appoints Two New Members to Board of Directors

Leading biomedical research organization welcomes Edward Mena, MD and Rick Wentzel, CPA

PASADENA, Calif.--(BUSINESS WIRE)--Huntington Medical Research Institutes (HMRI), a leading biomedical research organization in Southern California with a 70-year track record of impact, announced it added Dr. Edward Mena and accountant Rick Wentzel to its board of directors.

“We are thrilled to welcome Edward and Rick to our board of directors,” Dr. Julia Bradsher, president and CEO of HMRI, said. “Their extensive insights, experience and guidance will play a critical role in continuing to execute HMRI’s mission of advancing scientific discovery and will help us scale our research organization over the next 10 years. Edward’s medical experience alongside Rick’s extensive financial expertise adds to the breadth of the existing board in bolstering HMRI’s strategic plan.”

Edward Mena, MD, MBA, FAASLD
Mena has more than 20 years of liver research and hepatology practice, currently serving as the medical director of Pasadena Liver Center and medical director-CEO of California Liver Research Institute. He previously worked at the HMRI Liver Center and later opened his own private practice and research facility focused on liver disease. His work over the years centered around improving liver care for diverse communities. His specialties include nonalcoholic fatty-liver disease in adult and pediatric patients, nonalcoholic steatohepatitis in response to chronic hepatitis C, and liver cancer. For his commitment to helping engage the broader healthcare community and the Latin community, he received the Hispanic Health Leadership Award in 2019 and the Health Care Visionary Award from the American Liver Foundation in 2020. After graduating from the University of Southern California Keck School of Medicine, he received his executive Master of Business Administration from the USC Marshall School of Business.

Rick Wentzel, CPA
For more than 30 years, Wentzel has exclusively served not-for-profit organizations and currently is an independent consultant, assisting organizations with operational reviews, board governance reviews and risk assessments. He previously served as Grant Thornton's, Audit Partner, West region not-for-profit and higher education practice leader. Additionally, Wentzel has over 35 years of public and private audit and accounting experience, serving a variety of industries, including higher education, healthcare and employee benefit plans. He held prominent positions at PricewaterhouseCoopers after launching his career at Coopers & Lybrand.

Mena and Wentzel join the distinguished HMRI Board of Directors, led by Board Chair Dr. Susan E. Kane. HMRI’s mission is to advance scientific discovery through innovative biomedical research to improve health outcomes and inspire the next generation of scientists. Learn more at www.hmri.org.

About HMRI
Based in Pasadena, California, Huntington Medical Research Institutes (HMRI) is an independent, nonprofit organization that advances scientific discovery through innovative biomedical research to improve health outcomes and inspire the next generation of scientists. For seventy years, HMRI has focused life-changing studies on diseases and conditions that impact the everyday lives of families. Our scientists seek solutions to daunting challenges, like Alzheimer’s disease, heart disease, consequences of toxicity of nicotine, smoking, and vaping, and biological basis of mental illness.

Contacts

MEDIA CONTACT:
Priya Shah
mPR, Inc. on behalf of HMRI
priya@mpublicrelations.com

Huntington Medical Research Institutes


Release Versions

Contacts

MEDIA CONTACT:
Priya Shah
mPR, Inc. on behalf of HMRI
priya@mpublicrelations.com

Social Media Profiles
More News From Huntington Medical Research Institutes

New Guidelines on Men with Erectile Dysfunction and Cardiac Health Published in the Journal of Sexual Medicine Concludes PDE-5 Inhibitors are Still Safe for the Cardiovascular System

PASADENA, Calif.--(BUSINESS WIRE)--25 years after Viagra hit the market, a group of experts from across the country examined the link between erectile dysfunction (ED) and heart health. Their summary and guidelines have now been published in the Journal of Sexual Medicine. They determined that PDE-5 inhibitors are still safe for the cardiovascular system. In March of 2023, a group of 17 interdisciplinary scientists and practitioners convened “The Princeton IV: PDE-5 Inhibitors and Cardiac Healt...

HMRI Celebrates Women’s History Month: ‘Women have been at the forefront of our most groundbreaking research for decades’

PASADENA, Calif.--(BUSINESS WIRE)--Huntington Medical Research Institutes (HMRI), a leading biomedical research organization in Southern California with a 70-year track record of impact, is observing Women’s History Month this March by celebrating leading women in science and honoring their roles in the achievements of the past, present and future. “At HMRI, we are focused on improving public health by creating a deeper understanding of the mechanics of the brain and the heart. Women are and ha...

Milestone Study Exploring the Significant Impact of ED Drugs on Men’s Cardiac Health Published in the Journal of Sexual Medicine

PASADENA, Calif.--(BUSINESS WIRE)--A comprehensive research study manuscript examining the impact of erectile dysfunction drugs on major adverse cardiovascular events (MACE) and mortality has been published by scientists from Huntington Medical Research Institutes (HMRI) in Pasadena, HealthCore Inc. and the University of California San Francisco. This study marks a significant medical milestone, as it’s the first time the association between the use of PDE-5i drugs and cardiovascular health has...
Back to Newsroom